Inicio › Cáncer de próstata › Pensilvania
Ensayos clínicos de Cáncer de próstata en Pensilvania
62 estudios sobre Cáncer de próstata buscan participantes en Pensilvania.
Ciudades en Pensilvania
- Philadelphia41 estudios
- Pittsburgh23 estudios
- Harrisburg8 estudios
- Lancaster5 estudios
- Erie5 estudios
- York5 estudios
- Scranton5 estudios
- Hazleton4 estudios
- Reading4 estudios
- Allentown3 estudios
- Chambersburg3 estudios
Texto oficial del estudio (inglés)
Treating Prostate Cancer That Has Come Back After Surgery With Apalutamide and Targeted Radiation Based on PET Imaging
- UPMC Altoona, Altoona
- UPMC-Heritage Valley Health System Beaver, Beaver
- Carlisle Regional Cancer Center, Carlisle
- y 26 más
ReclutandoFase 3
Edades de 18 en adelante · Hombres · Actualizado el 13 nov 2026 · NCT04423211Study of AMG 509 in Participants With Metastatic Castration-Resistant Prostate Cancer
- Thomas Jefferson University, Philadelphia
- University of Pittsburgh Medical Center, Pittsburgh
ReclutandoFase 1
Edades de 18 en adelante · Hombres · Actualizado el 12 nov 2026 · NCT04221542Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors
- Lehigh Valley Hospital-Cedar Crest, Allentown
- Lehigh Valley Hospital - Muhlenberg, Bethlehem
- Pocono Medical Center, East Stroudsburg
- y 8 más
ReclutandoFase 2
Edades de 18 en adelante · Todos los sexos · Actualizado el 12 nov 2026 · NCT03866382Sacral Neuromodulation for Male Overactive Bladder (MOAB)
- MidLantic Urology, Bala-Cynwyd
Reclutando
Edades de 18 en adelante · Hombres · Actualizado el 12 nov 2026 · NCT06511141Circulating Tumor DNA in High Risk Localized Prostate Cancer
- UPMC Hillman Cancer Center, Pittsburgh
ReclutandoEstudio observacional
Edades de 18 en adelante · Hombres · Actualizado el 9 nov 2026 · NCT07222436First-Time-in-Human Study of GSK5471713 in Adults With mCRPC
- GSK Investigational Site, Philadelphia
ReclutandoFase 1/2
Edades de 18 en adelante · Hombres · Actualizado el 9 nov 2026 · NCT07332455Study of Oral MRT-2359 With Apalutamide in Prostate Cancer
- Lancaster Urology, Lancaster
ReclutandoFase 2
Edades de 18 en adelante · Hombres · Actualizado el 5 nov 2026 · NCT07745361Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
- Lehigh Valley Hospital-Cedar Crest, Allentown
- Lehigh Valley Hospital - Muhlenberg, Bethlehem
- Geisinger Medical Center, Danville
- y 7 más
ReclutandoEstudio observacionalSe aceptan voluntarios sanos
Edades de 40 a 75 · Todos los sexos · Actualizado el 4 nov 2026 · NCT05334069A Study of LY4257496 in Participants With Cancer (OMNIRAY)
- University of Pittsburgh Medical Center, Pittsburgh
ReclutandoFase 1
Edades de 18 en adelante · Todos los sexos · Actualizado el 4 nov 2026 · NCT07114601Distance-Based Exercise to Preserve Function and Prevent Disability
- UPMC Hillman Cancer Center at Butler Health System, Butler
- UPMC Hillman Cancer Center - Passavant - Cranberry, Cranberry Township
- IRMC Cancer Center, Indiana
- y 6 más
Reclutando
Edades de 18 en adelante · Todos los sexos · Actualizado el 4 nov 2026 · NCT07059884A Study to Learn About the Investigational Drug Rinzimetostat (ORIC-944) in Patients With mCRPC Who Were Previously Treated With Abiraterone Acetate (Himalayas-1)
- MidLantic Urology LLC, Bala-Cynwyd
- Keystone Urology Specialists, Lancaster
ReclutandoFase 3
Edades de 18 en adelante · Hombres · Actualizado el 3 nov 2026 · NCT07723248A Study of JNJ-87189401 Combined With JNJ-78278343 for Advanced Prostate Cancer
- Sidney Kimmel Cancer Center - Jefferson Health, Philadelphia
ReclutandoFase 1
Edades de 18 en adelante · Hombres · Actualizado el 3 nov 2026 · NCT06095089Testing the Addition of Docetaxel (Chemotherapy) to the Usual Treatment (Hormonal Therapy and Apalutamide) for Metastatic Prostate Cancer, ASPIRE Trial
- Saint Vincent Hospital, Erie
- Jefferson Hospital, Jefferson Hills
- Forbes Hospital, Monroeville
- y 8 más
ReclutandoFase 3
Edades de 18 en adelante · Hombres · Actualizado el 3 nov 2026 · NCT06931340A Study of [225Ac]Ac-AKY-2519 in Patients With Metastatic Castration-Resistant Prostate Cancer
- UPMC, Pittsburgh
ReclutandoFase 1
Edades de 18 en adelante · Hombres · Actualizado el 2 nov 2026 · NCT07581184A Clinical Study of Ifinatamab Deruxtecan (I-DXd) in People With Metastatic Prostate Cancer (MK-2400-001)
- Perelman Center for Advanced Medicine ( Site 0067), Philadelphia
- Abramson Cancer Center - Penn Medicine ( Site 0079), Philadelphia
ReclutandoFase 3
Edades de 18 en adelante · Hombres · Actualizado el 30 oct 2026 · NCT06925737Study of JANX007 in Subjects With Metastatic Castration-Resistant Prostate Cancer (ENGAGER-PSMA-01)
- Penn State Milton S. Hershey Medical Center, Hershey
- Thomas Jefferson University Honickman Center, Philadelphia
- UPMC Hillman Cancer Center, Pittsburgh
ReclutandoFase 1
Edades de 18 a 100 · Hombres · Actualizado el 29 oct 2026 · NCT05519449Extending Prostate Genetic Awareness, Navigation, and Delivery: The EXPAND Network
- Sidney Kimmel Cancer Center at Thomas Jefferson University, Philadelphia
ReclutandoEstudio observacionalSe aceptan voluntarios sanos
Edades de 18 en adelante · Hombres · Actualizado el 29 oct 2026 · NCT05627219Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer
- UPMC-Heritage Valley Health System Beaver, Beaver
- Carlisle Regional Cancer Center, Carlisle
- Christiana Care Health System-Concord Health Center, Chadds Ford
- y 24 más
ReclutandoFase 3
Edades de 18 en adelante · Hombres · Actualizado el 23 oct 2026 · NCT05946213Peer Navigation for the Support of Metastatic Prostate Cancer Patients Undergoing Genetic Evaluation
- Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University, Philadelphia
Reclutando
Edades de 18 en adelante · Hombres · Actualizado el 22 oct 2026 · NCT05487846A Study of Opevesostat (MK-5684) Versus Alternative Next-generation Hormonal Agent (NHA) in Metastatic Castration-resistant Prostate Cancer (mCRPC) Post One NHA (MK-5684-004)
- MidLantic urology ( Site 0022), Bala-Cynwyd
- Fox Chase Cancer Center ( Site 0076), Philadelphia
ReclutandoFase 3
Edades de 18 en adelante · Todos los sexos · Actualizado el 20 oct 2026 · NCT06136650A Study of Xaluritamig Plus Abiraterone Versus Investigator's Choice in Participants With Chemotherapy-naïve Metastatic Castration-resistant Prostate Cancer
- University of Pittsburgh Medical Center, Pittsburgh
ReclutandoFase 3
Edades de 18 en adelante · Hombres · Actualizado el 20 oct 2026 · NCT07213674AZD2265 Compared With Standard of Care in PSMA-positive Metastatic Castration-resistant Prostate Cancer (VECTRA-01)
- Research Site, Pittsburgh
ReclutandoFase 3
Edades de 18 en adelante · Hombres · Actualizado el 19 oct 2026 · NCT07611110A Study of Metastases Free Survival With Saruparib vs Placebo Added to a Standard RT/ADT in Men With High-risk Prostate Cancer With a BRCA Mutation
- Research Site, Hershey
- Research Site, Lancaster
- Research Site, Pittsburgh
ReclutandoFase 3
Edades de 18 en adelante · Hombres · Actualizado el 14 oct 2026 · NCT06952803This Study Will Explore Whether a Combination of the Investigational Drug Mevrometostat (PF-06821497) and Enzalutamide Will Work Better Than Taking Enzalutamide Alone in Participants With mCSPC Who Are ARPI naïve.
- MidLantic urology, Bala-Cynwyd
- The Centers for Advanced Urology d/b/a Keystone Urology Specialist, Lancaster
ReclutandoFase 3
Edades de 18 en adelante · Hombres · Actualizado el 14 oct 2026 · NCT07028853Standard Systemic Therapy With or Without Definitive Treatment in Treating Participants With Metastatic Prostate Cancer
- Chambersburg Hospital, Chambersburg
- Geisinger Medical Center, Danville
- Ephrata Cancer Center, Ephrata
- y 7 más
ReclutandoFase 3
Edades de 18 en adelante · Hombres · Actualizado el 8 oct 2026 · NCT03678025FOG-001 in Locally Advanced or Metastatic Solid Tumors
- University of Pennsylvania, Perelman School of Medicine, Philadelphia
- University of Pittsburgh Medical Center, Hillman Cancer Center, Pittsburgh
ReclutandoFase 1/2
Edades de 18 en adelante · Todos los sexos · Actualizado el 7 oct 2026 · NCT05919264The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
- Abramson Cancer Center of the University of Pennsylvania, Philadelphia
- University of Pittsburgh Medical Center, Pittsburgh
- WellSpan York Cancer Center, York
ReclutandoFase 1/2
Edades de 12 en adelante · Todos los sexos · Actualizado el 2 oct 2026 · NCT04585750DESTINY-PANTUMOUR04
- Research Site, Philadelphia
ReclutandoEstudio observacional
Edades de 18 a 130 · Todos los sexos · Actualizado el 25 sept 2026 · NCT07124000Open-label Study Comparing AAA817 Versus Standard of Care in the Treatment of Previously Treated PSMA-positive mCRPC Adults Who Have Disease Progressed on or After [177Lu]Lu-PSMA Targeted Therapy
- Fox Chase Cancer Center, Philadelphia
ReclutandoFase 2/3
Edades de 18 a 100 · Hombres · Actualizado el 22 sept 2026 · NCT06780670Carboplatin or Olaparib for BRcA Deficient Prostate Cancer
- Philadelphia MultiService Center, Philadelphia, PA, Philadelphia
ReclutandoFase 2
Edades de 18 en adelante · Hombres · Actualizado el 17 sept 2026 · NCT04038502Trial of Xaluritamig in Adults With Metastatic Castration-resistant Prostate Cancer
- Thomas Jefferson University, Philadelphia
- University of Pittsburgh Medical Center Hillman Cancer Center, Pittsburgh
ReclutandoFase 1
Edades de 18 en adelante · Hombres · Actualizado el 15 sept 2026 · NCT07493512Patient Navigation Program to Improve Clinical Trial Enrollment in Cancer Patients
- Wellspan, Chambersburg
Reclutando
Edades de 18 en adelante · Todos los sexos · Actualizado el 3 sept 2026 · NCT06138067Safety and Efficacy of AGN-INM176 in Prostate Patients With Rising PSA
- Penn State Cancer Institute, Hershey
ReclutandoFase 1/2
Edades de 40 en adelante · Hombres · Actualizado el 31 ago 2026 · NCT06600698A Study of Tarlatamab for People With Prostate Cancer
- Thomas Jefferson University Hospital, Philadelphia
ReclutandoFase 2
Edades de 18 en adelante · Hombres · Actualizado el 31 ago 2026 · NCT07111507A Study of Talazoparib With or Without Enzalutamide in People With Prostate Cancer Who Have Previously Received Abiraterone Acetate or Darolutamide
- Abramson Cancer Center of the University of Pennsylvania, Hospital of the University of Pennsylvania, Philadelphia
ReclutandoFase 2
Edades de 18 en adelante · Hombres · Actualizado el 21 ago 2026 · NCT06844383Evaluation of Neoadjuvant Xaluritamig in Localized Prostate Cancer
- Thomas Jefferson University, Philadelphia
ReclutandoFase 1
Edades de 18 en adelante · Hombres · Actualizado el 31 jul 2026 · NCT06613100Study of Orally Administered MOMA-313 in Participants With Advanced or Metastatic Solid Tumors
- Investigative Site #109, Philadelphia
ReclutandoFase 1
Edades de 18 en adelante · Todos los sexos · Actualizado el 23 jul 2026 · NCT06545942Docetaxel to Androgen Receptor Pathway Inhibitors in Patients With Metastatic Castration Sensitive Prostate Cancer and Suboptimal PSA Response
- Christiana Care Health System-Concord Health Center, Chadds Ford
- Geisinger Medical Center, Danville
- Geisinger Cancer Center Dickson City, Dickson City
- y 6 más
ReclutandoFase 3
Edades de 18 en adelante · Hombres · Actualizado el 14 jul 2026 · NCT06592924Study of ORIC-944 in Patients With Metastatic Prostate Cancer
- MidLantic Urology, Bala-Cynwyd
- Keystone Urology Specialists, Lancaster
ReclutandoFase 1
Edades de 18 en adelante · Hombres · Actualizado el 9 jul 2026 · NCT05413421A Study of Tinengotinib (TT-00420) in Combination With Standard Treatments in People With Prostate Cancer
- Thomas Jefferson University Hospital, Philadelphia
ReclutandoFase 1/2
Edades de 18 en adelante · Hombres · Actualizado el 25 jun 2026 · NCT06457919De ClinicalTrials.gov, datos obtenidos el 15 nov 2026. Cada estudio establece sus propios criterios de elegibilidad; el equipo del estudio decide quién puede participar.